RTP drug developer expands pipeline, seeks $20M Series A round


A small pharma company in RTP is expanding its portfolio and staff following a new licensing agreement with a California firm.

Previous Health plan startup focused on Hispanic-owned businesses moves into New Mexico
Next As summer wraps up, here's where the housing market stands